Uro/Renal Flashcards

1
Q

Metabolic Acidosis mudpiles

A

High-Anion Gap ⇢ MUDPILES
#MCC + ingestions
M: methanol (formic acid)
U: uremia (AKI/CKD, rhabdomyolysis)#
K: ketoacidosis (diabetic, alcoholic, starvation)#
P: propylene glycol
I: iron/isoniazid
L: lactic acidosis
E: ethylene glycol (oxalic acid)
S: salicylates (e.g., ASA)

Lactic Acidosis:
*Type A: related to hypoxia (e.g., septic or hypovolemic shock, hypoxemia, carbon monoxide poisoning)
*Type B: not related to hypoxia (e.g., liver failure, seizures, ETOH/methanol intoxication, isoniazid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Metabolic Acidosis primary disturbance vs compensation

A

Primary Disturbance: ⇣ pH (<7.4), ⇣ HCO3 (<24)
*loss of bicarb or gain of H+

Calculate anion gap: [Na] – [Cl + HCO3]
*high-anion gap (>12mEq/L) ⇢ “MUDPILES” ⇢
*normal (6-12mEq/L) ⇢ calculate UAG

UAG: [urine Na] + [urine K] – [urine Cl]
*⊖UAG ⇢ GI HCO3 loss (diarrhea) ⇢
*⊕UAG ⇢ RTA (⇣ renal acid excretion)

Respiratory Compensation: ⇡ RR ⇢ hyperventilation = ⇣ PCO2 (<40)
Expected PCO2: ⇣ [PCO2] 1.3mmHg per 1mEq/L ⇣ [HCO3]
*full compensation expected within 12-24h

DX: ketones, lactate, BUN/creatinine +/- tox screen
TX: directed at underlying cause (lactic acidosis, ketoacidosis, etc.)
*renal failure: give alkali (NaHCO3, sodium citrate) +/- dialysis
*ethylene glycol/methanol OD: fomepizole + HD

TX: Na, K, & HCO3 repletion PRN
TX: correct metabolic abnormalities to prevent nephrocalcinosis/CKD
*Distal: NaHCO3, often requires K supplementation
*Proximal: NaHCO3 or KHCO3 (more needed), thiazide diuretic
*⇡⇡ K: fludrocortisone, restrict dietary K, furosemide, NaHCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Metabolic Alkalosis causes

A

*volume depletion & hypokalemia are MC stimuli for ⇡ HCO3 reabsorption
Chloride Responsive (urine Cl <20mEq/L): chloride/ECFV loss, Cl repletion = correction
*Contraction alkalosis: ▪loop/thiazide diuretics, sweat loss in cystic fibrosis
▪︎vomiting/NG suction (HCl loss), congenital chloride diarrhea
*Renal H+ loss:
▪︎post-hypercapnia

Chloride Unresponsive (urine Cl >20mEq/L): severe K/Mg ⇣ or mineralocorticoid ⇡⇡, Cl repletion ≠ correction
*Mineralocorticoid excess:
▪︎1°/2° aldosteronism, congenital adrenal hyperplasia, hyperreninism
⊕HTN
▪︎CHF, cirrhosis w/ ascites, nephrotic syndrome

▪︎Liddle’s: pseudohypoaldosteronism (epithelial Na channel defect)

▪︎glycyrrhizic acid (licorice) ingestion (mimics mineralocorticoid excess)
*Genetic ion transport d/o:
▪︎Bartter ⇢ NaCl reabsorption defect in loop of Henle (mimics loops)
⊘HTN (normo/hypo)
▪︎Gitelman ⇢ NaCl reabsorption defect in DCT (mimics thiazides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metabolic Alkalosis primary disturbance and compensation

A

Primary Disturbance: ⇡ pH (>7.4), ⇡ HCO3 (>24)
*loss of H+ or gain of bicarb

Urinary Cl <20mEq/L ⇢ chloride responsive ⇢
Urinary Cl >20mEq/L ⇢ chloride unresponsive ⇢
*Urinary K <30mEq/L ⇢ laxative abuse, severe ⇣ K
*Urinary K >30mEq/L ⇢ look at BP
⊘HTN: Bartter, Gitelman
⊕HTN: consider mineralocorticoid excess

Respiratory Compensation: ⇣ RR ⇢ hypoventilation = ⇡ PCO2 (>40)
Expected PCO2: ⇡ [PCO2] 0.7mmHg per 1mEq/L ⇡ [HCO3]
*full compensation expected within 12-24h

TX: IV 0.9% NaCl (NS), treat underlying cause
TX: patients w/ severe alkalosis (pH >7.6) sometimes require more urgent correct of blood pH
*hemodialysis an option if volume overloaded + renal dysfunction
*Acetazolamide 250-375mg ⇡ HCO3 excretion but may also
accelerate urinary losses of potassium & phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Respiratory Acidosis (hypercapnia) acute vs chronic

A

ACUTE:
*acute lung disease (e.g., pneumonia, pulmonary edema), acute COPD/asthma exacerbation
*CNS depression d/t head trauma, postictal state, drugs (e.g., opiates, BDZs), OSA
S/SXS: HA, confusion, anxiety, drowsiness, tremor, blunted DTRs, myoclonic jerks, asterixis +/- papilledema

CHRONIC:
*airway obstruction (e.g., COPD/asthma)
*respiratory muscle weakness (e.g., Myasthenia gravis, ALS, Guillain-Barre, Multiple Sclerosis)
S/SXS: may be well tolerated, but may have memory loss, sleep disturbances, excessive daytime sleepiness, personality changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Respiratory Acidosis primary vs compensation

A

Primary Disturbance: ⇣ pH (<7.4), ⇡ PCO2 (>40)
*hypoventilation (retain CO2)

ACUTE TX:
*noninvasive ventilation (BiPAP) to blow off CO2
*invasive ventilation (trach) sometimes needed
*Naloxone for opioid OD

Metabolic Compensation: ⇡ HCO3 reabsorption (>24)
Expected HCO3, Acute: ⇡ [HCO3] 1mEq/L per 10mmHg ⇡ [PCO2]
Expected HCO3, Chronic: ⇡ [HCO3] 3.5mEq/L per 10mmHg ⇡ [PCO2]
*full compensation expected within 3-5d

CHRONIC TX:
*directed at underlying cause
*chronic hypercapnia must be corrected slowly (i.e., over hours to
minutes) because lowering PCO2 too rapidly can cause post-
hypercapnic “overshoot” alkalosis ⇢ seizures, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Respiratory Alkalosis acute vs chronic

A

ACUTE: **think ⇢ pain, anxiety, or hypoxemia (e.g., high altitude, pneumonia, PE, ARDS)
*fever, sepsis, stroke, seizures (postictal)
*mechanical overventilation, drugs (e.g., salicylates, theophylline, progesterone)
S/SXS: lightheadedness, confusion, peripheral/circumoral paresthesias, cramps, syncope
*hypocalcemia ⇢ carpopedal spasms

CHRONIC: PE during pregnancy, liver failure, hyperthyroidism, brainstem tumor
S/SXS: asymptomatic, no specific signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Respiratory Alkalosis primary vs compensation

A

Primary Disturbance: ⇡ pH (>7.4), ⇣ PCO2 (<40)
*hyperventilation (blow off CO2)

Metabolic Compensation: ⇣ HCO3 reabsorption (<24)
Expected HCO3, Acute: ⇣ [HCO3] 2mEq/L per 10mmHg ⇣ [PCO2]

Chronic: ⇣ [HCO3] 5mEq/L per 10mmHg ⇣ [PCO2]

TX: directed at underlying cause
*not life-threatening, pH lowering interventions not needed
*DISCOURAGE paper bag breathing ⇢ doesn’t fix PCO2 & may ⇣ PO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

AKI definition, sx, dx, tx

A

AKI: sudden loss of renal function w/ subsequent BUN/Cr ⇡

Defined as any of the following: ➀ SCr ⇡ ≥0.3mg/dL within 48h ➁ SCr ⇡ ≥1.5x baseline within 7d ➂ Urine output <0.5mL/kg/h for ≥6h

S/SXS: symptoms of uremia may develop later as nitrogenous
products accumulate ⇢ anorexia, N/V, weakness, confusion,
myoclonic jerks, seizures, coma
PE: +/- asterixis & hyperreflexia

» Uremic pericarditis: pleuritic CP worse when supine, improves w/ leaning forward
▪︎⊕pericardial friction rub

Phase:
➀ Onset phase
▪︎S/SXS of underlying cause may be present, urine output <0.5mL/kg/h Hours-days
(kidney injury)

➁ Oliguric/Anuric phase
▪︎progressive deterioration of kidney function
1-3wks (maintenance phase)
» oliguria (urine output <400mL/d); <50mL/d = anuria
» ⇡ BUN & creatinine (azotemia)

▪S/SXS: volume overload (e.g., peripheral & pulmonary edema, HF, HTN), metabolic acidosis, hyperkalemia, uremic symptoms

➂ Diuretic phase
▪︎GFR returns to normal, urine production ⇡ (polyuria), but tubular ~2wks reabsorption remains disturbed (i.e., can excrete but not concentrate urine) ⇢ fluid/electrolyte loss: hyponatremia, hypokalemia, dehydration)

➃ Recovery phase ▪︎normalization of kidney function & urine production Months-1y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Prerenal AKI causes, dx, tx

A

*MCC of AKI

PATHO: any condition that leads to decreased renal perfusion (MCC, ~60%)
» Hypovolemia: GI loss (e.g., V/D, bleeding), renal losses (e.g., diuretics), sweat/burns, 3rd-spacing
» Hypotension: shock (e.g., hypovolemic, myocardial, septic)
» Edematous states: heart failure (⇣ CO), cirrhosis
» Afferent (preglomerular) arteriolar dilation (e.g., NSAIDs, calcineurin inhibitors)
» Efferent (postglomerular) arteriolar constriction (e.g., ACEI/ARBs)

dx
▪︎BUN/Cr ratio >20:1
▪︎FENA <1%
▪︎UNa <20mEq/L
▪︎urine osmolality >500mOsm/kg
▪︎urinary sediment ⇢ hyaline casts

tx
▪︎IV fluid resuscitation for hypovolemia
▪︎DC offending drugs
▪︎hemodynamic support as indicated (e.g., shock)

*rapid improvement in w/ acute intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Postrenal AKI definition, dx, tx

A

PATHO: bilateral obstruction of urinary flow from renal pelvis to urethra
» Acquired obstructions (e.g., BPH, catheter injuries, tumors, stones, bleeding w/ clot formation)
» Neurogenic bladder (e.g., multiple sclerosis, spinal cord lesions, peripheral neuropathy)
» Congenital malformations (e.g., posterior urethral valves)

dx
▪︎⇡ creatinine in bilateral obstruction
▪︎urine osmolality <350mOsm/kg
▪︎postvoid residual volume >200mL suggests BOO
▪︎urinary sediment ⇢ normal, red cells, white cells, or crystals
*BUN/Cr ratio, FENA, & UNa vary
Renal U/S ⇢ hydroureter/hydronephrosis

tx
Bladder outlet obstruction (BOO):
▪︎urethral catheterization to relieve obstruction
Ureteral or renal pelvic obstruction:
▪︎ureteral stenting, percutaneous nephrostomy

*rapid improvement w/ obstruction relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute Tubular Necrosis causes, dx, tx

A

*MC intrinsic AKI

ATN: caused by either ischemic damage or toxins; tubules necrose, die, & slough off
» Ischemic: renal hypoperfusion most often caused by hypotension or sepsis
» Nephrotoxins: IV contrast, aminoglycosides, amphotericin B, NSAIDs, cyclosporine, vancomycin
▪︎Heme pigments: myoglobinuria (rhabdomyolysis), hemoglobinuria (hemolysis)
▪︎Endogenous toxins: uric acid (tumor lysis syndrome), Bence-Jones proteins (multiple myeloma)

dx
▪︎BUN/Cr ratio <20:1 ▪︎FENA >1%
▪︎urine osmolality <350mOsm/kg ▪︎UNa >20mEq/L
▪︎urinary sediment ⇢ muddy brown granular casts, renal tubular epithelial cells

tx
▪︎DC any potential nephrotoxins
▪︎supportive therapy w/ IV fluids
» Oliguric: strict fluid balance monitoring
» Polyuric: replace fluid/electrolyte losses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute Interstitial Nephritis definition, sx, dx, tx

A

AIN: inflammatory infiltrate & edema affecting the renal interstitium; develops over days to months
▪︎inflammatory infiltrates ⇢ tissue edema & tubular cell damage ⇢ compromised tubular flow
▪︎allergic: drugs act as haptens ⇢ type IV hypersensitivity reaction

» Medications (MCC): β-lactams (e.g., ciprofloxacin, isoniazid), macrolides (e.g., vancomycin,
rifampin), NSAIDs, anticonvulsants (e.g., CBZ, phenytoin, valproate)

» Bacterial infections: Brucella, Legionella, Mycobacterium, Salmonella, staph/strep

» Viral infections: CMV, EBV, HCV, HIV, mumps

» Autoimmune: Sjogren syndrome, sarcoidosis, SLE, cryoglobulinemia

dx
S/SXS: AKI +/- morbilliform rash, fever, arthralgias, flank pain
▪︎BUN/Cr ratio <20:1
▪︎urinary sediment ⇢ white cells, white cell casts +/- eosinophils

tx
▪︎DC causative agents, treat underlying disease
▪︎AKI supportive therapy x3-5d
Glucocorticoids ⇢ indications:
▪︎drug-induced AIN, autoimmune AIN
▪︎postinfectious AIN w/ delayed recovery
▪︎insufficient GFR ⇡ after 3-5d of supportive TX
▪︎impending indication for dialysis
▪︎diffuse infiltrates w/o extensive fibrosis on BX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute Glomerulonephritis types

A

» Poststreptococcal GN: usually affects children 3-12yo, self-limiting
▪︎occurs after group A strep infections ⇢ 1-2wks after pharyngitis (MC), 3-4wks after skin infection (impetigo)
▪DX: ⊕ASO, ⊕ADB, ⇣ C3

» IgA Nephropathy (Berger disease): MCC of AGN; young males within days (24-48h) after URI/GI infection
▪︎PATHO: IgA immune complex deposition
▪︎DX: ⇡ IgA, normal C3
▪︎S/SXS: gross hematuria & flank pain + acute URI
▪︎BX: mesangial IgA immune complex deposits

» Membranoproliferative GN (MPGN): associated w/ SLE, HCV, & cryoglobulinemia
▪︎glomerular injury d/t immune complex deposition &/or a complement-mediated mechanism
▪︎MC mixed nephritic-nephrotic syndrome
▪︎DX: ⇣ C3/C4

» Alport syndrome (hereditary nephritis): genetic defect in type IV collagen; most often X-linked, ♂︎ > ♀︎
▪︎S/SXS: isolated persistent hematuria, sensorineural hearing loss, anterior lenticonus
▪︎BX: variable thickening/thinning of GBM (basket-weave appearance)

» Rapidly progressive GN (RPGN): severe manifestations of glomerulonephritis
▪︎renal function declines rapidly over days to weeks; poor prognosis (ESRD within weeks to months)
▪︎BX: crescent formation made of plasma proteins & fibrin
➀ Goodpasture syndrome (anti-GBM antibody disease): antibodies against type IV collage of the GBM
▪︎peaks: 20-30yo (♂︎ > ♀︎), 60-70yo (♀︎ > ♂︎)
▪︎S/SXS: AGN + hemoptysis
▪︎DX: ⊕anti-GBM antibodies, normal C3
▪︎BX: linear IgG deposits along GBM
➁ Small vessel vasculitis: lack of immune complex deposition (pauci-immune)
Ⓐ Granulomatosis w/ polyangiitis (Wegener’s): ⊕C-ANCA
Ⓑ Microscopic polyangiitis: ⊕P-ANCA

dx
S/SXS: hematuria (i.e., cola-colored urine), HTN
▪︎AKI symptoms, edema (less than nephrotic)

LABS: proteinuria <3.5g/d, often ⇣ C3

AKI ⇢ ▪︎BUN/Cr ratio >20:1
▪︎UNa <20mEq/L
▪︎FENA <1%
▪︎urinary sediment ⇢ RBC casts*

tx
TX: supportive AKI therapy plus

▪︎sodium/water restriction
▪︎symptomatic azotemia: dialysis

Protein &/or HTN: ACEI/ARBs
Severe HTN &/or edema: diuretics

Poststreptococcal GN ⇢ ABX
▪︎PCN (throat), topical mupirocin (skin)

Alport: kidney transplant only definitive TX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lupus Nephritis definition, sx, dx, tx

A

PATHO: mesangial/subendothelial immune complex deposition (e.g., anti-dsDNA/anti-Sm Ab), expansion/thickening of mesangium, capillary walls, &/or GBM

» Class I Minimal mesangial ▪︎S/SXS: hematuria, edema, foaming urine, HTN

» Class II Mesangial proliferative ▪︎DX: UA + creatinine, confirm w/ renal BX

» Class III Focal proliferative
» Class IV Diffuse proliferative ▪︎TX: cyclophosphamide + prednisone
» Class V Membranous
» Class VI Sclerosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nephrotic Syndrome definition, sx, dx, tx

A

Kidney disease characterized by proteinuria, hypoalbuminemia, hyperlipidemia, & edema

Membranous Nephropathy: MCC in Caucasian males >40yrs
*may be seen w/ SLE, viral hepatitis, malaria, meds (Penicillamine), hypocomplementemia

Focal Segmental Glomerulosclerosis
*in the setting of HTN, heroin, HIV
*African Americans

sx
*generalized edema (esp. periorbital in children) usually worse in the morning
*may develop frothy urine – ascites & anasarca if severe
*anemia
*DVT – loss of protein C, S, & antithrombin III + liver production of more clotting proteins

dx
UA: initial test – proteinuria causing “foamy urine,” lipiduria
*Microscopy: oval Maltese cross-shaped fat bodies (fatty casts)

*urine albumin: creatinine ratio
*24hr urine protein >3.5g/d gold standard

*hypoalbuminemia, hyperlipidemia

Renal Bx – definitive dx
*Minimal Change Disease: podocyte damage seen on electron microscope
*Membranous Nephropathy: thick basement membrane

tx
*glucocorticoids – first line for Minimal Change Disease; FSGS
Edema reduction:
*diuretics, 1L fluid & sodium restriction
Proteinuria reduction: ACEI/ARBs
Hyperlipidemia: diet modification, statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Benign Prostatic Hyperplasia (BPH) definition, sx, dx, tx

A

Prostate hyperplasia (periurethral or transitional zone) leading to bladder outlet obstruction

Common in older men – hyperplasia is part of the normal aging process & is dependent on increased DHT production

sx
Irritative sxs: increased frequency, urgency, nocturia

Obstructive sxs: hesitancy, weak or intermittent stream force, incomplete emptying, & terminal dribbling

Sympathomimetics & anticholinergics may worsen the sxs

dx
DRE: uniformly enlarged, firm, nontender, rubbery prostate

PSA: normal <4ng/mL

UA: to look for hematuria or other cause of sxs

Urine cytology if increased risk of bladder cancer

tx
Mild sxs: observation (monitored annually)

Alpha blockers: best initial therapy to rapidly relieve sxs but do not change prostate size
*tamsulosin
*terazosin
*doxazosin

5-alpha reductase inhibitors: reduce the size of the prostate over 6-12mo
*finasteride, dutasteride

Surgical: TURP, laser prostatectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alpha-1 Blockers MOA
Tamsulosin
Alfuzosin
Doxazosin
Terazosin

A

Indications: provides rapid symptom relief but no effect on the clinical course of BPH

MOA: smooth muscle relaxation of prostate & bladder neck, leading to decreased urethral resistance, obstruction relief, & increased urinary outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

5-alpha Reductase Inhibitors MOA
Finasteride
Dutasteride

A

Indications: BPH & male pattern baldness

MOA: androgen inhibitor – inhibits the conversion of testosterone to DHT suppressing prostate growth, reduces bladder outlet obstruction
*doesn’t provide immediate relief but has a positive effect on clinical course of BPH (size reduction & decreases need for surgery); reduction of size in 6-12mo

20
Q

Chronic Kidney Disease & ESKD definition

A

Normal GFR in young adults ~125mL/min/1.73m2
Etiologies: diabetes MCC of ESKD, HTN 2nd MCC
RF: DM, HTN, family hx, ≥60yo, AA, Hispanic, Asian/Pacific Islander, American Indian, NSAIDs, AKI hx

Cardiovascular disease is the leading cause of morbidity/mortality in CKD

*Kidney Failure: end stage of CKD, defined as severely ↓ kidney function OR dialysis treatment
*ESKD/ESRD (GFR <15): chronic kidney failure treated w/ either dialysis or transplantation

CKD Definition: presence of either kidney damage or ↓ kidney function for ≥3mo

Types of Structural/Functional Abnormalities:
Pathologic Abnormalities:
*Glomerular diseases (diabetes, autoimmune disease, systemic infections, drugs, neoplasia)
*Vascular diseases (atherosclerosis, HTN, ischemia, vasculitis, thrombotic microangiopathy)
*Tubulointerstitial diseases (UTI, stones, obstruction)
*Cystic disease (polycystic kidney disease, “PKD”)

Urinary sediment abnormalities:
*RBC casts, proliferative glomerulonephritis
*WBC casts, pyelonephritis or interstitial nephritis
*Oval fat bodies or fatty casts, diseases w/ proteinuria
*Granular casts & renal tubular epithelial cells in many parenchymal diseases (non-specific)

21
Q

Chronic Kidney Disease & ESKD sx

A

CKD stages 1-4 are asymptomatic
*when GFR falls to ~10-15, nonspecific s/sxs begin to appear (e.g., malaise, weakness, insomnia, inability to concentrate, N/V)
*oliguria/anuria rare in CKD alone, almost always indicates at least some component of AKI

Cardiovascular Manifestations:
volume overload, edema, systemic HTN
*ischemic heart disease (d/t accelerated atherosclerosis)
*LVH, HF, rhythm disturbances
*uremic pericarditis (pleuritic chest pain)

Skin Manifestations:
*pale (anemia), hyperpigmented (↑ β-MSH production)
*pruritis +/- scratching lesions
*ecchymoses & hematomas (d/t bleeding diathesis)
*uremic frost (i.e., crystallization of urea), uncommon
*skin necrosis (calciphylaxis) & bullous lesions (rare)

Gastrointestinal Manifestations:
*anorexia & N/V (typical of advanced kidney failure)
*malnutrition
*uremic fetor (i.e., urinelike breath odor d/t urea + saliva forming ammonia), often associated w/ metallic taste
*inflammatory/ulcerative lesions & GI bleeding

Neurologic Manifestations:
*CVAs (d/t accelerated atherosclerosis)
*uremic encephalopathy (progressive cognitive impairment leading to seizures & coma if untreated)
*uremic neuropathy (i.e., central, peripheral, & autonomic neuropathy), RLS or burning feet syndrome

Hematologic Manifestations:
*normocytic, normochromic anemia (primarily d/t insufficient EPO production)
*abnormal leukocyte/immune system functions (more frequent & severe infections)
*platelet dysfunction (bleeding, bruising)

Endocrine & Metabolic Manifestations:
*impotence, infertility, ↓ libido (d/t hypogonadism)
*amenorrhea & galactorrhea (d/t hyperprolactinemia)
*insulin resistance + glucose intolerance (azotemic pseudodiabetes), hyperlipidemia

CKD-Mineral & Bone Disorders (CKD-MBD)
Mineral Abnormalities: hyperphosphatemia + hypocalcemia + low vitamin D (calcidiol & calcitriol) lead to secondary hyperparathyroidism (i.e., ↑ bone turnover)
Bone Manifestations (renal osteodystrophy): *all characterized by bone pain & easy fractures
*osteitis fibrosa cystica (brown tumors)
*adynamic bone disease (calcifications), *MC in dialysis pts
*osteomalacia, “soft bones” (growth retardation)

22
Q

Chronic Kidney Disease & ESKD dx

A

Initial workup: CBC, CMP, urine dipstick & microscopy, ACR & PCR on random urine sample

*↑ BUN (ref. range 7-20mg/dL)
*↑ creatinine
(ref. range 0.6-1.2mg/dL, female)
(ref. range 0.5-1.1mg/dL, male)
Albumin is the main protein lost through urine in CKD
*Proteinuria is best marker of progression

*anemia (↓ H/H)
*hyperphosphatemia
*hypocalcemia
*hyperkalemia
*metabolic acidosis
*hypermagnesemia
*hyperuricemia

Urinary sediment: +/- broad waxy casts
*result of dilated, hypertrophic nephrons

Evaluation of Metabolic Bone Disease:
*serum calcium, phosphorus, vitamin D, PTH

Other levels to evaluate: Hgb, iron, vitamin B12, folate

IMAGING:
Renal U/S: most useful imaging study, initial TOC
*BL small (<10cm), echogenic kidneys suggest chronic scarring of advanced CKD
*normal/enlarged kidneys can be seen w/ PKD, diabetic nephropathy, HIV-associated nephropathy, plasma cell myeloma, amyloidosis, obstructive uropathy

Doppler ultrasonography: useful if renovascular ischemic disease suspected

23
Q

Chronic Kidney Disease & ESKD tx

A

*dietary modifications
*treat reversible causes
*slow progression
*treat complications of kidney failure
*identify patients that will require kidney replacement therapy

Dietary Modifications:
*protein 0.8-1.0g/kg/d
*fiber 20-25g/d
*sodium <2g/d
*potassium 40-70meq/d, avoid NSAIDs
*phosphorous 600-800mg/d
*calcium 1400-1600mg/d
*iron ≥10-18mg/d

BP Control: ACEI/ARBs, diuretics
*goal 125-130/<80
Proteinuria: ACEI/ARBs, SGLT2s
Glucose Control: SGLT2s, GLP-1s
HLD: statins
*TC goal <200mg/dL
*LDL goal <100mg/dL

Volume overload:
*salt restriction + diuretic therapy
Metabolic acidosis:
*bicarbonate supplement
Hyperphosphatemia:
*Non-calcium PO phosphate binders (sevelamer, lanthanum)
Anemia: ESAs
*erythropoietin, darbepoetin alfa

Indications for Nephrologist Referral:
*GFR <30, ACR ≥300, PCR ≥500
*abnormal urine microscopy (cellular casts, non-urologic hematuria, sterile pyuria)
*difficult to manage lab abnormalities
*resistant HTN
*inability to identify a cause

24
Q

Bladder Carcinoma definition, sx, dx, tx

A

Transitional cell carcinoma MC type
3x MC in men than women
Risk Factors: smoking

sx
Painless hematuria in a smoker

dx
Cystoscopy w/ bx: gold standard

tx
Endoscopic resection w/ cystoscopy every 3mo
*recurrent or multiple lesions can be treated w/ intravesical chemotherapy

25
Q

Epididymitis definition, sx, dx, tx

A

Epididymal pain & swelling thought to be secondary to retrograde infection or reflux of urine – bacterial infection MC

Etiologies:
*males 14-35: chlamydia trachomatis (MC), Neisseria gonorrhea
*men >35: E. coli MC

S/SXS: gradual onset (hours to days) of unilateral testicular pain & swelling
▪︎groin, flank, or abdominal pain

+/- fever/chills, irritative sxs (urgency, frequency, dysuria)
PE:
▪︎scrotal swelling/tenderness
▪︎epididymal tenderness & induration
⊕Prehn sign: relief of pain w/ scrotal elevation
⊕cremasteric reflex: stroking of inner thigh causes elevation of ipsilateral testis

dx
Scrotal U/S – enlarged epididymis, increased testicular blood flow
UA: pyuria (↑ WBCs) or bacteriuria
NAAT for gonorrhea & chlamydia

tx
Scrotal elevation, NSAIDs, cool compresses

<35yrs: doxycycline (100mg BID x10d) + ceftriaxone (250mg IM x1)

> 35yrs: FQs (ciprofloxacin, ofloxacin, levofloxacin)

26
Q

Hydrocele definition, sx, dx, tx

A

Serous fluid collection within the layers of the tunica vaginalis of the scrotum

Etiologies: idiopathic MCC

Types:
*Communicating: peritoneal/abdominal fluid enters the scrotum via a patent processus vaginalis that failed to close
*Noncommunicating: derived from fluid from the mesothelial lining of the tunica vaginalis (no connection to the peritoneum)

sx
*painless scrotal swelling

PE:
*translucency (transilluminates)
*fluid located anterior/lateral to the testis

dx: Testicular U/S

tx
Usually no tx needed (watchful waiting)
*often resolves within the first 12mo of life in infants
*often self-limited in adults

Refractory: surgical excision

27
Q

Varicocele definition, sx, dx, tx

A

*cystic testicular mass of varicose veins: pampiniform venous plexus & internal spermatic vein

MC surgically correctable cause of male infertility

Most are left sided (increased left renal vein pressure transmitted to left gonadal vein)

sx
Asymptomatic varicocele found in 10% of population

*may cause testicular atrophy
*usually painless but may ⇢ dull ache, heavy sensation

PE:
▪︎“bag of worms” feel superior to testicle
▪︎dilation worsens when pt is upright or w/ Valsalva

dx: clinical
U/S – dilation of pampiniform plexus >2mm

tx
Observation in most

Surgery:
*pain, infertility, delayed testicular growth

ASSOCIATIONS:
*right sided: retroperitoneal/abdominal cancer
*sudden onset left sided in older man: RCC

28
Q

Testicular Torsion definition, sx, dx, tx

A

*spermatic cord twists & cuts off testicular blood supply due to congenital malformation

Highest Risk: males 10-20yrs, neonates

PATHO: insufficient fixation of the lower pole of the testis to the tunica vaginalis (Bell-clapper deformity), leading to increased mobility of the testicle

sx
ABRUPT ONSET: scrotal, inguinal, or lower abdominal pain
▪︎N/V

PE:
▪︎swollen, tender, retracted testicle (high-riding), may have horizontal lie
⊖Prehn sign: no pain relief w/ scrotal elevation
⊖cremasteric reflex: no elevation of testicle after stroking the inner thigh

dx
Clinical DX: in pts w/ H&P suggestive of torsion, imaging should NOT be performed **immediate surgical exploration

Emergency surgical exploration (definitive)
▪︎preferred over U/S if torsion is very likely

Testicular Doppler U/S
▪︎decreased or absent testicular blood flow

tx
*urgent detorsion & orchiopexy (ideally within 6hrs of pain onset)
*irreversible damage after 12hrs
*orchiectomy if not salvageable

29
Q

Erectile Dysfunction (ED) definition, types, sx, dx, tx

A

Definition: consistent or recurrent inability to generate or maintain an erection

Risk Factors: atherosclerosis (HTN, smoking, hyperlipidemia, diabetes), meds, sickle cell disease, hx of pelvic surgery or perineal trauma, ETOH abuse, hypothyroidism, congenital penile curvature

Medications: beta blockers, thiazide diuretics, spironolactone, CCBs, SSRIs, TCAs

Types
Vascular: MCC!
*atherosclerosis, diabetes, CKD,
Neurologic:
*stroke, seizures, MS, SCI
Psychogenic *abrupt onset
*normal nocturnal erections
*depression, stress
Hormonal:
*GnRH, LH, testosterone

dx
Detailed hx & PE
*DRE
*neuro exam

Labs: CBC, chemistry panel, fasting glucose, lipids

Hormones:
*serum testosterone
*prolactin, thyroid studies

Nocturnal penile tumescence:
*normal erections 🡪 psychogenic cause

Duplex U/S *evaluate penile blood flow

tx
First line: PDE-5 Inhibitors
*Sildenafil, Tadalafil, Vardenafil

Second line: intracavernosal injection therapy
*Prostaglandin E1 (Alprostadil)
*Papaverine +/- Phentolamine

Testosterone replacement therapy

Surgical:
*vacuum pump
*penile prosthesis
*revascularization surgery

30
Q

Hydronephrosis definition, sx, dx, tx

A

Water inside kidney 🡪 distention/dilation of pelvis and calyces by obstruction of free flow of urine from kidney

sx
*May be palpable abdominal or flank mass

dx
*Increased BUN/Cr
*Electrolyte imbalance
*IV urogram, US, CT, MRI

tx
*Remove obstruction/drain urine
*Nephrostomy tube: upper tract
*Catheter: lower tract

31
Q

Renal Cell Carcinoma definition, sx, dx, tx

A

Tumor of the proximal convoluted renal tubule cells (they are very metabolically active cells so they are the most prone to dysplasia)

95% of primary tumors originating in the kidney
*Clear Cell Carcinoma MC

Characterized by lack of warning signs, variable presentations, & resistance to chemo/radiation

Risk Factors: smoking, HTN, obesity, men, dialysis, cadmium or industrial exposure

sx
Triad:
*hematuria
*flank or abdominal pain
*palpable abdominal mass

*HTN & hypercalcemia
Tumors blocks left testicular vein drainage 🡪 left-sided varicocele
*malaise, weight loss
METS: cannon ball METS to lungs (MC site); bone

dx
CT (initial)
Renal U/S, MRI
Erythrocytosis often present

tx
Stage I-III: radical nephrectomy
*immune-mediated therapy (e.g., interleukin-2 & monoclonal antibody molecular targeted treatment) – usually resistant to radiation/chemo

Bilateral involvement of solitary kidney:
*partial nephrectomy

Advanced disease:
*molecularly targeted agents
*debulking nephrectomy

32
Q

Renal Artery Stenosis definition, sx, dx, tx

A

HTN secondary to renal artery stenosis of 1 or both kidneys
*MCC of secondary HTN

PATHO: decreased renal blood flow leads to activation of RAAS

Etiologies:
*atherosclerosis MC in the elderly
*fibromuscular dysplasia MC in women <50yrs

sx
*HA
*<20yrs or >50yrs w/ HTN
*severe HTN
*HTN resistant to 3 or more drugs

PE:
*abdominal bruit
ACEI 🡪 acute kidney injury!!!!!

dx
*CT angiography
*MR angiography
*duplex doppler U/S

Renal catheter arteriography 🡪 GOLD STANDARD*

tx
Definitive 🡪 revascularization
*angioplasty w/ stent
*bypass

Medical: ACEI/ARBs *CI if bilateral stenosis
*thiazide diuretics
*long-acting CCB
*mineralocorticoid receptor antagonist

33
Q

Nephrolithiasis types, definition, sx, dx, tx

A

Types:
*calcium oxalate (MC), calcium phosphate
*uric acid: high protein foods, gout, chemo
*struvite: magnesium ammonium phosphate
*cystine: congenital defect in reabsorption

sx
Renal colic: sudden, constant upper lateral back or flank pain over the CVA radiating to the groin or anteriorly; difficult to find a comfortable position
N/V, frequency, urgency, hematuria
PE: CVA tenderness

dx
UA:
*hematuria
*pH <5.0: uric acid, cystine
*pH >7.2: struvite

Non-contrast CT abdomen/pelvis
KUB x-ray: calcium & struvite stones are radiopaque

tx
<5mm:
- 80% chance of spontaneous passage
- IV fluids, analgesics, antiemetics
- tamsulosin

5-10mm:
- 20% chance of spontaneous passage
- extracorporeal shock wave lithotripsy
- ureteroscopy w/ or w/o stent: immediate relief of obstruction
- percutaneous nephrolithotomy: stones >10mm

34
Q

Osmolality vs osmolarity

A

Osmolality: dissolved particles per unit mass (mOsm/kg)

Osmolarity: solutes concentration per unit volume (mOsm/L)

35
Q

Crystalloids vs colloids

A

Crystalloids: aqueous solutions w/ varying concentrations of electrolytes
*Most commonly used fluids in hospital setting, ⇡ intravascular (ECF) volume
Types: isotonic, hypotonic, hypertonic
Colloids: solutions that contain larger molecular weight solutes (e.g., albumin, starch)
*solutes mostly remain confined to intravascular compartment
*NOT routinely used for fluid resuscitation
Natural Colloids: albumin, FFP
Artificial Colloids: gelatins, dextrans, hydroxyethyl starch (HES)

36
Q

Volume Depletion (Hypovolemia) definition and causes

A

HYPOVOLEMIA:
*secondary to loss of sodium AND water from ECF
*results in compromised tissue perfusion
Etiology:
*GI losses: vomiting, diarrhea, bleeding
*Renal losses: diuretics, hypoaldosteronism, osmotic
diuresis via glucosuria, salt-wasting nephropathies
*Skin losses: sweat, burns
*Third-spacing sequestration: intestinal obstruction,
crush injury, ascites, pancreatitis/peritonitis
Compensatory Mechanisms:
*RAAS activation ⇢ Na & H2O reabsorption
*ADH release ⇢ H2O reabsorption

DEHYDRATION:
*H2O loss from ICF ⇢ ECF hypertonicity (⇡ Na)
*H2O net shift: ICF ⇢ ECF
Etiology: insensible losses, diabetes insipidus
S/SXS: secondary to hypernatremia (e.g., HA, confusion, dizziness)
Compensatory Mechanisms:
*activation of thirst center ⇢ increased intake
*ADH release ⇢ H2O reabsorption

37
Q

Hypovolemia vs dehydration

A

hypovolemia = Na and H2O loss

dehydration = free water loss

38
Q

Volume Depletion (Hypovolemia) sx

A

S/SXS related to VOLUME DEPLETION:
*lack of energy, easy fatigability, thirst, muscle cramps
*postural dizziness, oliguria

S/SXS related to FLUID LOSS ETIOLOGY:
*V/D, polyuria, severe skin burn
*pain caused by underlying third-spacing mechanism

S/SXS related to ELECTROLYTE ABNORMALITIES:
*hyponatremia ⇢ N/V, lethargy, confusion, seizures
*hyperkalemia ⇢ N/V/D, ileus, muscle weakness
*acidosis ⇢ tachypnea
*alkalosis ⇢ neuromuscular irritability (spasms)

Physical Exam:
*⇣ interstitial volume ⇢ skin/mucous membrane signs
▪︎ dry skin, ⇣ turgor, tenting, dry mucous membranes
*⇣ plasma (intravascular) volume ⇢ SBP & JVP reductions
▪︎ SBPΔ as severity of volume deficit increases
⤷ ~NML ⇢ orthostasis ⇢ posture-independent low SBP
▪︎ ⇣ intensity of Korotkoff sounds & radial pulse
▪︎ ⇣ JVP

*Hypovolemic Shock ⇢ tachycardia, cold/clammy extremities, cyanosis, low UO <15mL/h, agitation, confusion

39
Q

Volume Depletion (Hypovolemia) dx

A

LABS:
*low urine volume (oliguria)
*BUN/creatinine ratio >20:1
*d/t ⇡ Na reabsorption & resultant ⇣ urea excretion
▪︎ ⇡ BUN (ref. 5-20mg/dL) ⇢ prerenal azotemia
▪︎ creatinine ⇡ only if loss severe enough to ⇣ GFR
*hyponatremia (ref. 135-145mEq/L)
*hyperkalemia (ref. 3.5-5.0mEq/L)
*acid-base disturbances *depends on mechanism of loss
▪︎ vomiting, diuretics (H+ loss) ⇢ metabolic alkalosis
▪︎ diarrhea (HCO3 loss) ⇢ metabolic acidosis
*Hct & albumin *depletion of plasma volume
▪︎ ⇡ Hct (i.e., relative polycythemia)
▪︎ ⇡ albumin (ref. 3.5-5g/dL)

DX: clinical, confirmed by low urine Na concentration
*urine Na <20mEq/L
*FENA <1%
*urine osmolality concentration >450mOsm/kg
▪︎ specific gravity >1.015
*UA normal in hypovolemia since kidney is not diseased
▪︎ i.e., ⊖protein, ⊖cells/casts

40
Q

Volume Depletion (Hypovolemia) tx

A

Resuscitation: IV fluid boluses
*20mL/kg IV NS or LR

Maintenance:
*calculate maintenance rate
*D5½NS + 20mEq KCl preferred

Monitor: I&Os, electrolytes, weight

41
Q

Volume Overload (Hypervolemia) definition, sx, dx, tx

A

Isotonic Hypervolemia (salt gain = H2O gain):
*intravascular overload of IV fluids w/ electrolytes
*postop/trauma stress causing ⇣ Na/H2O excretion
*renal insufficiency, cirrhosis, CHF

Hypotonic Hypervolemia (salt gain < H2O gain):
*replacement of GI losses w/ NaCl-poor solutions
*third-spacing, ⇡ ADH w/ surgical stress, SIADH

Hypertonic Hypervolemia (salt gain > H2O gain):
*excessive Na load w/o adequate H2O intake

sx
*tachypnea, orthopnea, weight gain
*pulmonary edema, crackles, rales
*ascites, pleural effusions
*⇡ JVD, peripheral edema, oliguria

Hypertonic ⇢ symptoms of sodium excess
*HA, confusion, dizziness, etc.

DX: mainly clinical
*serum Na (ref. 135-145mEq/L)

Supportive labs/imaging:
*CXR, ECHO
*NT-proBNP

tx
*sodium & water restriction
*loop diuretics
*dialysis may be required if severe

42
Q

Polycystic Kidney Disease definition, sx, dx, tx

A

Autosomal dominant polycystic kidney disease (ADPKD) is a relatively common genetic condition resulting from mutation of the PKD1/PKD2 gene

Growth of numerous cysts in kidneys made of epithelial cells from renal tubules; can 🡪 kidney failure/ESRD

sx
*>30yrs, + family hx, abdominal mass
Classic presentation 🡪 young pt w/ back/flank pain & HTN
10% have brain aneurysms (worry when they complain of the worse HA of life)
Cardiovascular abnormalities: MVP, LVH

dx
U/S 🡪 many fluid-filled cysts
CT: large renal size; multiple thin-walled cysts
Anemia

UA:
*proteinuria, hematuria
*pyuria, bacteriuria

tx
No cure!!!
BP control – ACEI/ARB for HTN
Treat infections w/ abx
Dialysis/transplant w/ renal insufficiency

43
Q

Prostate Cancer definition, sx, dx, tx

A

Adenocarcinoma MC type (95%)
*peripheral zone MC area

Risk Factors: age, family hx, AA

Screening: DRE & PSA level
*white male = 50yrs
*black male, + FH, or +BRCA mutation = 40yrs

sx
*difficulty w/ urination
*frequency, urgency, urinary retention
*decreased urinary stream

DRE:
*hard, indurated, nodular, enlarged, asymmetrical prostate
Back or bone pain 🡪 METS

dx
PSA (normal <4ng/mL), DRE, transrectal U/S
*PSA >10 🡪 transrectal U/S w/ bx
*abnormal DRE 🡪 transrectal U/S w/ bx
*PSA <4, normal DRE 🡪 annual follow-up
*PSA 4-10, normal DRE 🡪 bx recommended

If PSA >10 🡪 order bone scan to r/o METS
Gleason grading system

tx
Radical prostatectomy – complication: ED
w/ METS: androgen deprivation therapy (leuprolide)
Monitor PSA: should be <0.1

44
Q

Prostatitis definition, sx, dx, tx

A

Prostate gland inflammation secondary to an ascending infection

Acute:
*>35yrs: E. coli MC
*<35yrs: gonorrhea & chlamydia

Chronic:
*E. coli MC
*proteus

sx
Irritative voiding sxs: frequency, urgency, dysuria

Obstructive sxs: hesitancy, poor or interrupted stream, straining to void, incomplete emptying

Acute: exquisitely tender prostate
*fever, chills, perineal pain

Chronic: nontender (or minimally tender) prostate
*usually presents as recurrent UTIs or intermittent dysfunction

PE: boggy prostate!!!!!

dx
UA & urine culture:
*acute: pyuria & bacteriuria
*chronic: + after massage!

AVOID prostatic massage in acute (may cause bacteremia)

tx
Acute:
>35: FQs or TMP-SMX x4-6wks
<35: ceftriaxone + doxycycline

Chronic: FQs or TMP-SMX x6-12wks
*tamsulosin can help w/ chronic pain

Refractory (chronic): TURP

45
Q

Acute Cystitis “bladder infection” “UTI”
definition, sx, dx, tx

A

PATHO: usually an ascending infection of the lower urinary tract from the urethra

Etiologies:
*E. coli MC
*staph saprophyticus 2nd MC in sexually active

sx
Irritative sxs: dysuria (burning), frequency, urgency
*hematuria, suprapubic pain & tenderness

dx
UA: pyuria (>10WBCs/hpf), hematuria, leukocytes esterase, nitrites, cloudy urine, bacteriuria

Urine culture: definitive
*epithelial (squamous cells) = contamination

tx
- nitrofurantoin or TMP-SMX
- FQs second line (“floxacin”)
- phenazopyridine (analgesic)
*turns urine orange

46
Q

Acute Pyelonephritis “kidney infection” definition, sx, dx, tx

A

Infection of the upper GU tract (kidney parenchyma & renal pelvis)
PATHO: usually an ascending infection of the lower urinary tract

Etiologies: E. coli MC
Risk Factors: DM, hx of recurrent UTIs or kidney stones, pregnancy, congenital urinary tract malformations

sx
Upper tract sxs: fever, chills, back/flank pain; N/V
Lower tract sxs: dysuria, urgency, frequency
PE:
+ CVA tenderness
Fever, tachycardia

dx
UA:
*pyuria (>10WBCs/hpf)
*leukocyte esterase
*nitrites
*hematuria, cloudy urine
*WBC casts – HALLMARK

CBC: leukocytosis w/ left shift
Urine culture: definitive

tx
Outpatient: FQs first line (“floxacin”)

Inpatient: cephalosporins, FQs, aminoglycosides, penicillins

ADMIT: older age, signs of obstruction, comorbid conditions, inability to tolerate PO abx

Pregnancy: IV ceftriaxone